Ozempic (Semaglutide) 0.5mg PFP 1’s is a once-weekly injectable medication used to improve blood sugar control in adults with type 2 diabetes. It contains semaglutide, a GLP-1 receptor agonist that helps regulate glucose levels by enhancing insulin secretion, reducing glucagon release, and slowing gastric emptying. Typically used after the initial starting dose, Ozempic 0.5mg supports better glycemic control and helps patients progress in their treatment plan under medical supervision.

Wegovy 0.5mg Injection contains semaglutide, a GLP-1 receptor agonist used as part of a structured weight management program. Typically prescribed after the initial 0.25mg starting dose, Wegovy 0.5mg helps reduce appetite, increase feelings of fullness, and support healthy weight loss when combined with a reduced-calorie diet and regular physical activity. This once-weekly prescription injection assists eligible adults and adolescents with obesity in progressing through their treatment plan under the guidance of a healthcare professional.